RAGE Gly82Ser polymorphism in diabetic microangiopathy [2]

Diabetes Care

Volumn 22, Issue 4, 1999, Pages 646-

  Liu, Limei ^a   Xiang, Kunsan ^a  

^a Dept of Endocrinol and Metabolism   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; GLYCINE; SERINE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; DIABETIC MICROANGIOPATHY; DIABETIC RETINOPATHY; DNA DETERMINATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PROTEIN POLYMORPHISM;

EID: 0344142389     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.4.646     Document Type: Letter

References (4)

1. Ayo SH, Radnik RA, Glass WF, Garoni JA, Rampt ER, Appling DR, Kreisberg JI: Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am J Physiol 260:F185-F191, 1991
2. Brownlee M: Glycation and diabetic complications. Diabetes 43:836-841, 1994
3. Schmidt AM, Hasu M, Popov D, Zhang JH, Chen J, Yan SD, Brett J, Cao R, Kuwabara K, Costache G, Simionescu N, Simonescu M, Stern D: Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulation AGE proteins. Proc Natl Acad Sci U S A 91:8807-8811, 1994
4. Hudson BI, Stickland MH, Grant PJ: Identification of polymorphisms in the receptor for advanced glycation end products (RAGE) gene: prevalence in type 2 diabetes and ethnic groups. Diabetes 47:1155-1157, 1998